Elucidating the specific pharmacological mechanism of action (MOA) of naturally developing compounds can be hard. Even though Tarselli et al. (sixty) made the primary de novo artificial pathway to conolidine and showcased that this naturally transpiring compound successfully suppresses responses to both chemically induced and inflammation-derived p